Aimei Health Technology CO., LTD. (AFJKR) — SEC Filings

Overview

Aimei Health Technology CO., LTD. (AFJKR) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 18, 2025: Aimei Health Technology Co., Ltd. (AFJKR) reported a net income of $352,019 for the three months ended September 30, 2025, a significant decrease from $743,510 in the same period of 2024. For the nine months ended September 30, 2025, net income was $961,651, down from $2,108,102 in the prior year, p

Sentiment Summary

Across 47 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 41 neutral, 2 mixed. The dominant filing sentiment for Aimei Health Technology CO., LTD. is neutral.

Filing Type Overview

Aimei Health Technology CO., LTD. (AFJKR) has filed 21 8-K, 6 10-Q, 4 DEF 14A, 1 10-K/A, 2 10-K, 1 DEFA14A, 4 SC 13G/A, 8 SC 13G with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (47)

• 8-K Filing — 8-K · Dec 8, 2025
• 8-K Filing — 8-K · Dec 2, 2025
• Aimei Health Tech's Net Income Halves Amid SPAC Extension Costs — 10-Q · Nov 18, 2025 Risk: high
  Aimei Health Technology Co., Ltd. (AFJKR) reported a net income of $352,019 for the three months ended September 30, 2025, a significant decrease from $743,510
• 8-K Filing — 8-K · Nov 12, 2025
• Aimei Health Seeks 12-Month SPAC Extension, Cuts Sponsor Fees — DEF 14A · Nov 10, 2025 Risk: high
  Aimei Health Technology Co., Ltd. (AFJKR) is seeking shareholder approval to extend its business combination deadline from December 6, 2025, to December 6, 2026
• Aimei Health Files 8-K on Financial Obligation — 8-K · Nov 4, 2025 Risk: medium
  On November 4, 2025, Aimei Health Technology Co., Ltd. filed an 8-K report. The filing indicates the creation of a direct financial obligation or an obligation
• Aimei Health to Merge with United Hydrogen in $1.5B Deal; Founder to Control 93% Vote — DEF 14A · Oct 10, 2025 Risk: high
  Aimei Health Technology Co., Ltd. (AFJKR) is proposing a business combination with United Hydrogen Group Inc., forming a new entity, Pubco (United Hydrogen Glob
• Aimei Health Technology Files 8-K on Financial Obligations — 8-K · Oct 9, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on October 9, 2025, reporting on events that occurred on October 8, 2025. The filing indicates the creation of a
• Aimei Health Files 8-K on Financial Obligations — 8-K · Sep 5, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on September 5, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balan
• Aimei Health Amends 10-K/A for China Risk, Advances United Hydrogen Merger — 10-K/A · Aug 26, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. (AFJKR), a blank check company, filed a 10-K/A on August 26, 2025, to amend its disclosures regarding risks associated with th
• Aimei Health Tech's Cash Dries Up Amidst SPAC Extension Costs — 10-Q · Aug 13, 2025 Risk: high
  Aimei Health Technology Co., Ltd. (AFJKR) reported a net income of $424,970 for the three months ended June 30, 2025, a decrease from $609,092 in the same perio
• Aimei Health Files 8-K on Financial Obligations — 8-K · Aug 6, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on August 6, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balance
• Aimei Health Technology Files 8-K on Financial Obligation — 8-K · Jul 7, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on July 7, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balance sh
• Aimei Health Files 8-K for Material Agreement — 8-K · Jun 11, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on June 11, 2025, reporting an entry into a material definitive agreement and financial statements. The filing da
• Aimei Health Files 8-K on Financial Obligations — 8-K · Jun 6, 2025 Risk: medium
  On June 6, 2025, Aimei Health Technology Co., Ltd. filed an 8-K report. The filing indicates the creation of a direct financial obligation or an obligation unde
• Aimei Health Technology Files Q1 2025 10-Q — 10-Q · May 14, 2025 Risk: low
  Aimei Health Technology Co., Ltd. filed a 10-Q report for the period ending March 31, 2025. The filing details financial information for the first quarter of 20
• Aimei Health Technology Files 8-K on Financial Obligations — 8-K · May 6, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on May 6, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balance she
• Aimei Health Technology Files 8-K on Financial Obligations — 8-K · Apr 7, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on April 7, 2025, reporting the creation of a direct financial obligation or an obligation under an off-balance s
• Aimei Health Files 2024 10-K — 10-K · Mar 28, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed its 10-K report for the fiscal year ending December 31, 2024, on March 28, 2025. The company, with its principal executi
• Aimei Health Files 8-K on Financial Obligation — 8-K · Mar 6, 2025 Risk: medium
  On March 6, 2025, Aimei Health Technology Co., Ltd. filed an 8-K report. The filing indicates the creation of a direct financial obligation or an obligation und
• Aimei Health Technology Reports Material Definitive Agreement — 8-K · Feb 7, 2025 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on February 7, 2025, reporting several material events as of February 5, 2025. These include entering into a mate
• Aimei Health Technology Files 8-K on Shareholder Votes — 8-K · Feb 4, 2025 Risk: low
  Aimei Health Technology Co., Ltd. filed an 8-K on February 4, 2025, reporting on a submission of matters to a vote of security holders. The company, incorporate
• Aimei Health Files Definitive Proxy Materials — DEFA14A · Jan 30, 2025 Risk: low
  Aimei Health Technology Co., Ltd. filed a DEFA14A on January 30, 2025, indicating it is providing definitive additional materials related to its proxy statement
• Aimei Health Technology Co., Ltd. Calls Shareholder Meeting — DEF 14A · Jan 21, 2025 Risk: low
  Aimei Health Technology Co., Ltd. filed a Definitive Proxy Statement (DEF 14A) on January 21, 2025. The filing concerns an upcoming Extraordinary General Meetin
• Aimei Health Technology Files 8-K on Financial Obligation — 8-K · Jan 14, 2025 Risk: medium
  On January 13, 2025, Aimei Health Technology Co., Ltd. filed an 8-K report detailing the creation of a direct financial obligation or an obligation under an off
• Aimei Health Files 8-K on Shareholder Votes & Financials — 8-K · Dec 31, 2024 Risk: low
  Aimei Health Technology Co., Ltd. filed an 8-K on December 23, 2024, reporting on matters submitted to a vote of security holders and financial statements. The
• Aimei Health Technology Files 8-K on Financial Obligations — 8-K · Dec 13, 2024 Risk: medium
  Aimei Health Technology Co., Ltd. filed an 8-K on December 13, 2024, reporting the creation of a direct financial obligation or an obligation under an off-balan
• Aimei Health Technology Co., Ltd. Files Definitive Proxy Statement — DEF 14A · Dec 3, 2024 Risk: low
  Aimei Health Technology Co., Ltd. filed a Definitive Proxy Statement (DEF 14A) on December 3, 2024, for its fiscal year ending December 31. The company, located
• SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• SC 13G Filing — SC 13G · Nov 14, 2024
• SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Aimei Health Technology Files 10-Q for Q3 2024 — 10-Q · Nov 13, 2024 Risk: medium
  Aimei Health Technology Co., Ltd. filed its 10-Q for the period ending September 30, 2024. The filing details financial information and business operations for
• SC 13G Filing — SC 13G · Oct 16, 2024
• Aimei Health Tech Files Q2 2024 10-Q — 10-Q · Aug 9, 2024 Risk: medium
  Aimei Health Technology Co., Ltd. filed its 10-Q for the period ending June 30, 2024. The filing details financial information for the second quarter and the fi
• Aimei Health Enters Material Definitive Agreement — 8-K · Jun 20, 2024 Risk: medium
  On June 19, 2024, Aimei Health Technology Co., Ltd. entered into a material definitive agreement. The company, incorporated in the Cayman Islands, filed this 8-
• Aimei Health Technology Co., Ltd. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024 Risk: low
  Aimei Health Technology Co., Ltd. (AFJKR) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Aimei Health Technology Co., Ltd. filed a 10-Q report fo
• Aimei Health Technology Announces Board and Officer Changes — 8-K · Apr 19, 2024 Risk: medium
  Aimei Health Technology Co., Ltd. announced on April 15, 2024, changes in its board of directors and executive officers. The company also reported on compensato
• SC 13G Filing — SC 13G · Apr 9, 2024
• Aimei Health Technology Co., Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024 Risk:
  Aimei Health Technology Co., Ltd. (AFJKR) filed a Annual Report (10-K) with the SEC on March 25, 2024. Aimei Health Technology Co., Ltd. filed its annual report
• SC 13G Filing — SC 13G · Mar 8, 2024
• SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• SC 13G Filing — SC 13G · Feb 14, 2024
• Wolverine Asset Management Takes 5.1% Stake in Aimei Health — SC 13G · Feb 8, 2024 Risk: low
  Wolverine Asset Management, LLC, a Chicago-based investment firm, reported owning 1,000,000 ordinary shares of Aimei Health Technology Co., Ltd. as of December
• Cowen & Co. Discloses Stake in Aimei Health Technology — SC 13G · Feb 2, 2024
  Cowen and Company, LLC, a major financial services firm, reported on February 2, 2024, that it holds a significant stake in Aimei Health Technology Co., Ltd. Th
• Harraden Circle Investments Discloses Passive Stake in Aimei Health Tech — SC 13G · Jan 31, 2024
  Harraden Circle Investments, LLC, a Delaware-based entity, has disclosed its ownership in Aimei Health Technology Co., Ltd. through an SC 13G filing on January
• Aimei Health Tech Confirms Nasdaq Listing for Shares, Rights, Units — 8-K · Jan 18, 2024
  Aimei Health Technology Co., Ltd. (AFJK) filed an 8-K on January 18, 2024, confirming its various securities, including Ordinary Shares (AFJK), Rights (AFJKR),

Risk Profile

Risk Assessment: Of AFJKR's 31 recent filings, 4 were flagged as high-risk, 19 as medium-risk, and 8 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Key financial metrics from Aimei Health Technology CO., LTD.'s most recent 10-Q filing (Nov 18, 2025):

• Revenue: $0
• Net Income: $961,651
• EPS: $0.15
• Debt-to-Equity: N/A
• Cash Position: $2,979
• Operating Margin: N/A
• Total Assets: $45,468,518
• Total Debt: $3,464,428

Key Executives

• Junheng Xie
• Xia Ma
• Han Huang
• Christopher L. Gust
• Robert R. Bellick

Industry Context

Aimei Health Technology operates as a blank check company, a segment of the financial services industry focused on facilitating mergers and acquisitions. The competitive landscape for SPACs is characterized by a race against time to identify and complete a viable business combination before their deadlines expire. Industry trends include increasing regulatory scrutiny and a growing emphasis on the quality and strategic fit of target companies.

Top Tags

financial-obligation (12) · 8-k (9) · SPAC (5) · filing (4) · 10-Q (4) · financials (4) · corporate-governance (3) · proxy-statement (3) · sec-filing (3) · Blank Check Company (2)

Key Numbers

• Net Income (9 months): $961,651 — Decreased from $2,108,102 in 2024, a 54.4% decline year-over-year.
• Cash Balance: $2,979 — Significantly reduced from $28,208 at December 31, 2024, indicating severe liquidity issues.
• Cash held in Trust Account: $45,443,570 — Decreased from $73,784,549 at December 31, 2024, due to share redemptions.
• Accumulated Deficit: $3,439,693 — Increased from $1,476,823 at December 31, 2024, reflecting growing losses.
• Extension loans– related party: $1,655,400 — Increased from $227,700 at December 31, 2024, highlighting reliance on related party funding for extensions.
• Ordinary shares subject to possible redemption: 3,995,733 — Reduced from 6,900,000 shares at December 31, 2024, due to redemptions.
• Cash withdrawn from Trust Account: $31,265,500 — Used for redemptions in connection with the February 5, 2025, stockholder vote.
• Number of extensions: 12 — The company has extended its business combination deadline twelve times, pushing it to December 6, 2025.
• Current business combination deadline: December 6, 2025 — Proposed to be extended by 12 months
• Proposed business combination deadline: December 6, 2026 — Represents a 12-month extension
• Per-share pro rata portion of Trust Account: $11.33 — As of September 26, 2025, near market price
• Closing price of AFJKR shares: $11.32 — As of September 26, 2025, Record Date
• Original IPO business combination period: 24 months — Being extended to 36 months
• Proposed total business combination period: 36 months — From IPO date, if extension is approved
• Current monthly extension fee: $150,000 — To be reduced if Trust Agreement Amendment Proposal is approved

Forward-Looking Statements

• {"claim":"Aimei Health Technology Co., Ltd. may see increased trading volume due to the institutional interest.","entity":"Aimei Health Technology Co., Ltd.","targetDate":"Q1 2024","confidence":"medium"}
• {"claim":"Other institutional investors might initiate or increase their positions in Aimei Health, following Wolverine's lead.","entity":"Aimei Health Technology Co., Ltd.","targetDate":"Q2 2024","confidence":"low"}

Related Companies

AFJK · AFJKU · AMH · UHL · AMEI

Frequently Asked Questions